Meta Pixel

News and Announcements

Australian Patent Granted for Use of Midkine for Hair Growth

  • Published January 13, 2015 1:49PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Source: ASX; Published: Sydney, 12th January 2015

Cellmid Limited (ASX:CDY) has received official Notice of Acceptance from IP Australia for Cellmid’s patent application 2011220326.

This patent protects the use of midkine and the closely related protein pleiotrophin for use as a hair loss and/or hair growth treatments. The granted claims cover topical formulations of all kinds, including shampoos, conditioners,creams and lotions with protection until 2031.

This patent family adds to the already considerable intellectual property assets of Cellmid’s wholly owned anti-aging hair growth subsidiary, Advagen, which include patent protection and extensive know-how around its FGF5 inhabiting technologies, cell based assays, formulations and brands.

To read the full announcement please download the document below.

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Join over 45,000+ sophisticated investors

Join Now